These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22461187)

  • 61. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis.
    Olofsson T; Söderling JK; Gülfe A; Kristensen LE; Wallman JK
    Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1712-1716. PubMed ID: 29885037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up.
    Caro-Oleas JL; Fernández-Suárez A; Reneses Cesteros S; Porrino C; Núñez-Roldán A; Wichmann Schlipf I
    Clin Exp Rheumatol; 2008; 26(3):461-3. PubMed ID: 18578970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors.
    Baker K; Pope J; Fortin P; Silverman E; Peschken C; ;
    Lupus; 2009 Dec; 18(14):1281-8. PubMed ID: 19854811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
    Quintana-Duque MA; Rondon-Herrera F; Mantilla RD; Calvo-Paramo E; Yunis JJ; Varela-Nariño A; Restrepo JF; Iglesias-Gamarra A
    Clin Rheumatol; 2016 Jun; 35(6):1463-73. PubMed ID: 27041382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; ; Hyrich KL; Verstappen SMM
    PLoS One; 2019; 14(5):e0215999. PubMed ID: 31107887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.
    Nordberg LB; Lillegraven S; Lie E; Aga AB; Olsen IC; Hammer HB; Uhlig T; Jonsson MK; van der Heijde D; Kvien TK; Haavardsholm EA;
    Ann Rheum Dis; 2017 Feb; 76(2):341-345. PubMed ID: 27094444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
    de Siqueira MB; da Mota LM; Couto SC; Muniz-Junqueira MI
    BMC Musculoskelet Disord; 2015 Jun; 16():159. PubMed ID: 26123215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
    Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA
    Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.
    Wolfe F; Hawley DJ
    J Rheumatol; 1998 Nov; 25(11):2108-17. PubMed ID: 9818651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis.
    Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Vestergaard A; Østergaard M; Hørslev-Petersen K
    J Rheumatol; 2009 Apr; 36(4):731-5. PubMed ID: 19273450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis.
    Li C; Zhang Y; Song H; Gao J; Zhao DB; Zhu Q; He DY; Wang L; Li XP; Liu XD; Xiao WG; Wu XY; Wu HX; Tu W; Hu SX; Wang X; Li ZJ; Lu ZM; Da ZY; Liang B; Liu XM; Zhao JW; Li L; Han F; Qi WF; Wei W; Ma X; Li ZB; Zheng GM; Zhang FX; Li Y; Wang YL; Ling GH; Chen JW; Hou XQ; Zhang J; Chen QP; Liu CL; Zhang Y; Zeng JS; Zou QH; Fang YF; Su Y; Li ZG
    Chin Med J (Engl); 2019 Dec; 132(24):2899-2904. PubMed ID: 31855969
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
    Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
    Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis.
    Majka DS; Deane KD; Parrish LA; Lazar AA; Barón AE; Walker CW; Rubertone MV; Gilliland WR; Norris JM; Holers VM
    Ann Rheum Dis; 2008 Jun; 67(6):801-7. PubMed ID: 17974596
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
    Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
    Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.
    Tan YK; Li H; Allen JC; Thumboo J
    Int J Rheum Dis; 2020 Oct; 23(10):1337-1343. PubMed ID: 33460311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Lapraik C; Marshall T; Lunt M; Verstappen SMM
    Rheumatology (Oxford); 2017 Sep; 56(9):1510-1517. PubMed ID: 28510734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.